Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Parental liver disease mortality is associated with unfavorable outcomes in patients with alcohol-associated hepatitis
Tu, Wanzhu , Tang, Qing , Kettler, Carla, Kamath, Patrick S. , Nagy, Laura E. , Liangpunsakul, Suthat, Shah, Vijay H. , Chalasani, Naga , Investigators, on behalf of the AlcHepNet, Gawrieh, Samer , Nephew, Lauren Devore , McClain, Craig J. , Dasarathy, Srinivasan , Vatsalya, Vatsalya , Simonetto, Douglas A. , Szabo, Gyongyi , BARTON, BRUCE A. , Yu, Yunpeng, Sanyal, Arun J. , Mitchell, Mack , Liangpunsakul, Suthat , Bataller, Ramon A , Investigators, on behalf of the AlcHepNet

Hepatology Communications | May 23, 2025 | Volume: 9 | Issue: 6 | Pages: No page available

10.1097/hc9.0000000000000666 | PMID 40408279 Get It

Background: How parental alcohol use disorder and liver disease-related mortality influence the risk and the outcomes of alcohol-associated hepatitis (AH) in the offspring is unknown. Methods: We analyzed data from 2 prospective observational studies of AH cases and heavy drinking controls (HDCs). Family history of parental alcohol use disorder and liver disease mortality was assessed at the study entry. Logistic regression and Cox proportional hazard models were used to assess the influences of family history on AH development and outcome. Results: Data from 1356 participants in two prospective cohorts (926 AH cases and 430 HDC) were combined and analyzed. Parental alcohol use disorder was found in 56.9% of AH cases and 61.1% of HDC; parental death due to liver disease was reported in 7.5% of AH cases and 5.7% of HDC. Multivariable logistic regression showed that parental liver disease-related mortality was associated with more than a doubled risk of AH development in the offspring after controlling for their demographic characteristics and drinking behavior (OR=2.26, 95% CI: [1.22, 4.20]). Moreover, among the AH cases, having a parent die of liver disease significantly increased the 90-day mortality of study participants after adjusting for the effects of other risk factors (HR=2.26, 95% CI: [1.05, 4.86]). Conclusions: The study highlights the influences of parental death due to liver disease on AH development and mortality. Identifying patients at risk of AH through family history might help facilitate discussions on reducing alcohol consumption.
Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinoma
Swancutt, Katy L. , Nicholson, James H., Alves, Elizabeth M. , Hamilton, Cassandra , Rusek, A., Davis, Anthony J. , Story, Michael D. , Aguilera, Todd A. , Elghonaimy, Eslam A , Pop, Laurentiu M , Sishc, Brock J. , Alves, Elizabeth M , Hamilton, Cassandra , Davis, Anthony J , Hannan, Raquibul , Aguilera, Todd A , Pop, Laurentiu M.

No container title available | May 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.17.654632 | PMID 40475579 Get It

Abstract The tumor landscape of pancreatic ductal adenocarcinoma (PDAC) is refractory to conventional photon radiotherapy (RT) due to a fibrotic tumor microenvironment (TME) that promotes chronic hypoxia and reduced immune surveillance. The radiobiological factors unique to carbon ion radiotherapy (CIRT), such as high linear energy transfer (LET) and less dependence on oxygen, make it well-suited to overcome the PDAC TME. Here, we utilized clonal syngeneic KPC pancreatic tumor cell lines and tumors to examine this postulate and to identify underlying factors that impact the response of PDAC to CIRT. While KPC cell lines exhibited radiobiologic effectiveness (RBE) greater than 3, subcutaneous tumors in the mouse hind leg showed lower RBEs – 1.3 based on quintupling time – at a LET of 75 keV/μm. Four days after CIRT, we observed widespread transcriptomic changes in the tumor immune microenvironment (TME), suggesting increased infiltration of anti-tumor immune cells, elevated expression of anti-tumor T cell cytokines, MHC class I molecules, and co-stimulatory signals. Fewer immunologic changes were observed following photon irradiation. By seven days after CIRT, tumor-supportive transcriptomic programs characterized by pro-tumor cytokines, M2 macrophages, and cancer-associated fibroblasts (CAFs) emerged, promoting resistance and limiting the durability of tumor growth delay. These findings suggest that CIRT may offer a favorable platform compared to conventional photon radiation therapy for combining with immunotherapies. Furthermore, these data highlight the risk of using in vitro survival data alone in treatment planning and indicate that underlying TME factors impact the response of PDAC in vivo .
Three Hundred Periprosthetic Tibial Fractures Around a Total Knee Replacement
Dugdale, Evan M. , Alter, Thomas D. , Stuart, Michael J. , Sems, S.A. , Yuan, Brandon J. , Spangehl, Mark J. , Springer, Bryan D. , Berry, Daniel J. , Abdel, Matthew P. , Sems, Stephen A , Abdel, Matthew P , Stuart, Michael J , Yuan, Brandon , Berry, Daniel J , Spangehl, Mark

Journal of Bone and Joint Surgery | May 23, 2025 | Volume: 107 | Issue: 14 | Pages: 1579-1589

10.2106/jbjs.24.01407 | PMID 40408445 Get It

Background: Periprosthetic tibial fractures around a total knee replacement (TKR) remain challenging to manage, with little published information for guidance. The purpose of this study was to review the types, management techniques, and outcomes of periprosthetic tibial fractures in the largest series to date. Methods: We identified 300 periprosthetic tibial fractures (285 patients) around a TKR (43% in primary TKRs and 57% in revision TKRs) sustained between 1996 and 2020. Fractures were classified according to Felix et al. as Type I (tibial plateau), Type II (adjacent to stem), Type III (distal to stem), or Type IV (tibial tubercle), with subtypes A (well-fixed component), B (loose component), and C (intraoperative fracture). Of the fractures in this study, 53% were Type I, 24% were Type II, 16% were Type III, and 8% were Type IV. A total of 46% of fractures occurred intraoperatively, and 54% of fractures occurred postoperatively (61% subtype A, 39% subtype B). The mean patient age at fracture was 67 years, and 64% of patients were female. The mean follow-up was 6 years. Results: The intraoperative fracture incidence was 1.40% in revision TKRs and 0.10% in primary TKRs. Among intraoperative fractures, the 2-year survivorship free from tibial component revision was highest in Type I (100%) and lowest in Type IV (67%) (p < 0.001). For postoperative fractures, the 2-year survivorship free from any reoperation was 29% and the 2-year survivorship free from tibial component revision was 51%. Type-I postoperative fractures had the lowest 2-year survivorship free from tibial component revision (10%), whereas Type-III fractures had the highest survivorship (88%) (p < 0.001). Conclusions: Intraoperative periprosthetic fracture of the tibia was fourteenfold more likely in revision TKRs compared with primary TKRs. Among all intraoperative fractures, Type-I fractures were well-tolerated, with 100% survivorship free from tibial component revision at 2 years. Conversely, Type-I postoperative fractures had only 10% survivorship at 2 years. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
Outcomes of medical and surgical management in infectious intracranial aneurysms: a multicenter cohort analysis
Alawieh, Ali , Zohdy, Youssef M. , Koo, Andrew B. , Saad, Hassan , Baba, Bachar El , Newman, Sarah, Grossberg, Jonathan A , Matouk, Charles , Cawley, C. Michael, Reisner, Andrew , Perez‐Vega, Carlos , Burkhardt, Jan‐Karl , Salem, Mohamed M , Jabbour, Pascal , Naamani, Kareem El, Gooch, M Reid, Starke, Robert M., Abdelsalam, Ahmed , Lu, Victor M , Chalhoub, Reda , Spiotta, Alejandro M , Alawieh, Ali M , Zohdy, Youssef M , Koo, Andrew B , El Baba, Bachar , Grossberg, Jonathan A , Matouk, Charles , Fox, W Christopher , Perez-Vega, Carlos , Jabbour, Pascal , Levitt, Michael R , Chalhoub, Reda M , Spiotta, Alejandro M , Howard, Brian M , Burkhardt, Jan‐Karl , Dimisko, Laurie , Pradilla, Gustavo , Naamani, Kareem El , Schmidt, Richard F. , Gooch, Michael Reid , Abdelsalam, Ahmed, Levitt, Michael R. , Kobeissy, Firas , Barrow, Daniel L.

Journal of NeuroInterventional Surgery | May 23, 2025 | Volume: 18 | Issue: 4 | Pages: 1079-1086

10.1136/jnis-2025-023421 | PMID 40409986 Get It

Introduction Infectious intracranial aneurysms (IIAs) are rare but serious complications of systemic infections, particularly infective endocarditis. These aneurysms are prone to rupture, leading to significant morbidity and mortality. Management strategies lack consensus due to the rarity of the condition and reliance on small case series. This study examines the clinical management of IIAs using data from a large multicenter cohort. Methods A retrospective registry-based cohort study was conducted across 11 tertiary care centers in the USA between 2018 and 2023. Patients with IIAs were identified based on clinical and radiographic criteria. The primary outcome was treatment failure defined as persistence, growth, or rupture of the aneurysm. Secondary outcomes were mortality and the modified Rankin Scale (mRS) score at 90 days and 1 year. Multivariate logistic regressions were used to identify outcome predictors. Results A total of 104 patients with 166 aneurysms were included, with a median age of 43 years. Medical management was successful in 56% of cases, with failure often within 18 days of initiation. Predictors of failure included younger age, larger aneurysm size, and rupture at presentation. Surgical and endovascular interventions achieved higher success rates with better outcomes. At 90 days, 57% of patients achieved functional independence (mRS 0–2), while the mortality rate was 24%. Conclusion This study highlights the limitations of medical management for IIAs and underscores the need for early surgical or endovascular intervention in high-risk patients. Outcome predictors aid clinical decision-making, optimizing patient management. Further research is needed to standardize management guidelines for IIAs.
Prelimbic cortical excitatory overdrive and inhibitory underdrive accompany environmental suppression of food seeking
Pedan, Zuzana, Agbude, Romarua, Woods, Emily , Steele, Oliver G. , Suto, Nobuyoshi , Kinghorn, Scott B. , Tsaponina, Olga , Peters, Kate Z. , Woods, Emily C., Koya, Eisuke

No container title available | May 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.21.655312 | PMID 40475591 Get It

Abstract Cues associated with food, such as fast-food advertising, can provoke food cravings and may lead to unhealthy overeating. Environmental enrichment (EE) that enhances cognitive and physical stimulation can reduce cue-evoked sucrose seeking in mice and recruitment of sucrose cue-reactive neurons or ‘neuronal ensembles’ in the prelimbic cortex (PL), which regulates appetitive behaviors. Hence, EE provides us with a behavioral model and neuronal targets to identify ‘anti-craving’ relevant mechanisms. Here, we investigated in the PL how EE modulated neuronal excitability and activity patterns in cue-reactive neuronal populations. Chemogenetic inhibition of cue-reactive neurons in PL blocked cue-evoked sucrose seeking, thereby confirming the function of these neurons in sucrose cue memory. EE boosted the baseline excitability of ‘originally’, or before EE exposure, cue-reactive, excitatory pyramidal cells in PL. Furthermore, their sucrose cue-specificity was lost – resulting in their persistent activation and non-cue selective activation or ‘excitatory overdrive’. Furthermore, EE reduced recruitment of cue-reactive, inhibitory interneurons reflecting ‘inhibitory underdrive’. Taken together, impaired neuronal food cue processing due to simultaneous prefrontal cortical excitatory ‘overdrive’ and inhibitory ‘underdrive’ likely underlies EE’s anti-craving action, thereby serving as potential neurophysiological targets to develop novel medications that help control food cravings.
Progression trajectories of chronic overlapping pain conditions unveiled across two large clinical data warehouses
Li, Haiquan , Baldwin, Edwin , Luo, Wenting , Hooten, W. Michael , Fan, Jungwei W, Baldwin, Edwin , Luo, Wenting , Fan, Jungwei , Zhou, Jin J.

Pain | May 23, 2025 | Volume: 166 | Issue: 11 | Pages: e543-e554

10.1097/j.pain.0000000000003650 | PMID 40408224 Get It

Abstract Chronic overlapping pain conditions (COPCs) affect a wide population and incur a substantial disease burden including comorbid mental disorders. Although these comorbidities have been extensively documented, the longitudinal trajectories of their onset, particularly for those with three or more conditions, have been rarely studied. We conducted retrospective cohort studies to identify statistically significant COPCs and mental health trajectories in the All of Us Research Program (AoU v8, 338,170 persons) and the Mayo Data Warehouse (3,957,444 individuals). For each trajectory, cases were matched with controls by demographic factors. Logistic regression was then applied to assess the increased likelihood of the final condition given the prior conditions in that sequence. The significant trajectories were visualized as a “pain forest.” More than 88% of trajectories identified from AoU (Male: 78, Female: 361) were reproducible in the Mayo Data Warehouse data (Male: 361, Female: 1286), with female trajectories encompassing more than 96% of the male trajectories. The findings indicate that chronic low back pain generally occurs earlier than other conditions, while fibromyalgia tends to follow other COPCs. Endometriosis seems to be associated with an increased prevalence of COPCs in women. In addition, longer trajectories are associated with a greater risk of developing additional COPC or mental condition. The results offer new insights into the progression of COPCs and associated mental conditions, which may inform healthcare providers and patients in managing and preventing exacerbation of these conditions.
Therapeutic Use of Transcutaneous Vagal Nerve Stimulation for Dizziness and Imbalance: An Integrative Review
Zaleski-King, Ashley , Bogle, Jamie M. , Williams, Sheniqua, Williams, Sheniqua, Kuchinsky, Stefanie E.

Perspectives of the ASHA Special Interest Groups | May 23, 2025 | Volume: 10 | Issue: 4 | Pages: 1161-1173

10.1044/2025_persp-24-00245 Get It

Purpose: Chronic dizziness and imbalance is often difficult to rehabilitate based on the complex set of systems involved. Recently, transcutaneous vagus nerve stimulation (tVNS) has been investigated as a noninvasive means to reduce symptoms associated with vestibular impairment, chronic dizziness, and neurological conditions affecting balance control. The purpose of this integrative review is to examine available data describing therapeutic efficacy and proposed mechanisms of tVNS in adult patients with dizziness and imbalance. Method: PubMed, Europe PMC, and Google Scholar searches were conducted using the following search terms from 1987 to 2024: “vagal nerve stimulat*” OR “vagus nerve stimulat*” OR “transcutaneous vagus nerve stimulat*” OR “tVNS” AND “dizziness,” “vertigo.” Articles were imported for screening and review through Rayyan. Articles discussing the use of tVNS to study metrics related to vestibular and balance function in adult humans were selected for full-text review. Results: Eleven articles were identified as meeting the inclusion criteria and are classified according to the neurotological class studied and level of evidence provided. Available data show that tVNS may benefit patients with dizziness and imbalance based on subjective metrics including quality of life and reduction in dizziness handicap. Less-controlled case study evidence suggests that additional benefit from tVNS may manifest in changes to vestibulo-ocular reflex function. Conclusion: Although tVNS exposure has provided variable degrees of benefit in both subjective (e.g., quality of life) and objective (e.g., changes in vestibulo-ocular reflex function and gait) contexts, the degree to which distinct mechanisms can explain these benefits is unclear.
Editorial Comment
Jeffery, Jaxson, Punjani, Nahid

Journal of Urology | May 23, 2025 | Volume: 214 | Issue: 2 | Pages: 165-165

10.1097/ju.0000000000004608 | PMID 40407073 Get It

Commentary: Assessment of the Subarcuate Canaliculus as a Landmark in Middle Fossa Surgery
Ríos-Zermeño, Jorge , Lucke‐Wold, Brandon , Rios Zermeno, Jorge

Operative Neurosurgery | May 23, 2025 | Volume: 30 | Issue: 3 | Pages: 453-453

10.1227/ons.0000000000001616 | PMID 40407700 Get It

Left atrial appendage morphology and dynamic parameters differ between patients with and without atrial fibrillation
Fidalgo, I, Saiz-Vivó, Marta , Albors, Carlos , Baan, J., Vis, Marije M. , Meijer, I, Fidalgo, I Van Der Snoek, Cámara, Óscar , Planken, R. Nils , de Groot, Joris R , Marquering, Henk A. , Arrarte Terreros, Nerea

Europace | May 23, 2025 | Volume: 27 | Issue: Supplement_1 | Pages: No page available

10.1093/europace/euaf085.514 Get It

Abstract Background Patients with atrial fibrillation (AF) are at increased risk of stroke, often arising from a thrombus in the left atrial appendage (LAA). In selected cases, left atrial appendage occlusion or closure is an alternative for stroke prevention with oral anticoagulation. To assess the risk of stroke and the benefit of LAA closure and to select the appropriate device, it is crucial to quantify the morphology and dynamics of the left atrial appendage (LAA). To date, much about LAA dynamics in this setting is unknown, and subsequently the risk of embolic stroke and inappropriate device positioning is insufficiently explored. Purpose We describe the morphological and dynamic differences of the left atrium (LA) and LAA in high risk AF patients compared to controls undergoing trans catheter aortic valve implantation (TAVI). Methods Our study population consists of 14 patients, seven with AF and seven without AF, undergoing TAVI, since dynamic computed tomography (CT) angiography scans are performed in the standard of care in these patients. The scans were acquired every 5% of the cardiac cycle (i.e., R-R interval on the ECG) (Figure 1a). The LA and LAA were semi-automatically segmented (Figure 1b) to determine the following parameters across the entire cardiac cycle: LA volume; LAA volume, depth, height, and length; and ostium area, eccentricity, and diameter. Results AF patients had a significantly larger LA volume (108 mL vs 68 mL, p=0.03), while the LA volume change throughout the cardiac cycle was similar in AF patients and controls. Both groups had an LA volume change of 35mL on average. Figure 1cd shows the LA and LAA volume curves of a patient with and without AF. The LAA ostium size and volume of AF patients exhibited larger dynamic variations than those from non-AF patients, while the ostium eccentricity in AF patients showed less variation and the ostium shape was rounder. Conclusions We found differences in morphologic and dynamic parameters of the LA and LAA between AF and non-AF patients. The morphology and dynamics of the LAA can increase the understanding of LAA thrombus formation. Moreover, it may have implications for the risk of embolic stroke and may assist in the selection of the optimal LAA closure device type and size.